Stay updated on Palbociclib After CDK and Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.

Latest updates to the Palbociclib After CDK and Endocrine Therapy Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check46 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a Phase II clinical trial for metastatic breast cancer and the addition of new collaborators and a revision number. Notably, the name of the principal investigator has been updated.SummaryDifference53%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 6, 2025.SummaryDifference0.1%
- Check61 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 6, 2025, and version 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Palbociclib After CDK and Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.